small molecule

DOCETAXEL

DOCETAXEL

Loss of exclusivityloss of exclusivity
CompanyShilpa MedicareSee this company's full patent-cliff portfolio

Drug detail

Brand nameDOCETAXEL
Active ingredientDOCETAXEL
Strength80MG/4ML (20MG/ML)
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalMay 2019
Marketing statusRX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

DOCETAXEL patent cliff — loss of exclusivity — | CliffBio